Dwarfism and the controversial drug trial | SBS Dateline

Achondroplasia, the most common form of dwarfism, is a rare genetic disorder that impacts bone growth, affecting around 1 in 25,000 children worldwide.

Australian researchers are leading a global drug trial aimed at boosting growth in children born with a form of dwarfism.

But some people of short stature are scared it will eradicate their community.

This episode first aired in 2021.

Subscribe to Dateline: https://bit.ly/3gkQHtr

Website http://www.sbs.com.au/news/dateline
Facebook   / datelinesbs  
Twitter   / datelinesbs  
Instagram   / datelinesbs  

Watch more Dateline, SBS 9.30pm Tuesday, and on SBS On Demand.

Dateline is an Australian award-winning international documentary series with a current affairs backbone.
Every week we transport you to a different part of the world to share half-hour stories about family, social injustice, identity, tragedy, redemption and survival. We scour the globe to bring you special characters and a world of daring stories.

Network Terms & Conditions: https://www.sbs.com.au/terms
Privacy Policy: https://www.sbs.com.au/privacy
Feedback or complaints: https://www.sbs.com.au/complaints